Clinical Trials Browser

Recruiting × Barrett Esophagus × 90 days × Clear all

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT05745857 2026-04-13

SLURP

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06748911 2026-04-03

DS-MCE-BE

Phase NA Recruiting

57 enrolled

Gastrointestinal

Barrett Esophagus

NCT07126535 2026-03-30

Impact of RFA on Esophageal Distensibility and Mucosal Impedance

Recruiting

10 enrolled

Gastrointestinal

Barrett Esophagus

NCT04312633 2026-03-20

Clinical Utility of WATS3D: A 5-Year Prospective Study

Recruiting

90,000 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Diseases, Gastroesophageal Reflux

NCT06803927 2026-03-18

DETECT-ME

Recruiting

700 enrolled

Gastrointestinal

Barrett Esophagus

NCT06523374 2026-02-24

Endeavor-1

Phase NA Recruiting

50 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms

NCT06346054 2026-02-17

MAGEC

Phase NA Recruiting

1,000 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT05468008 2026-02-02

ESD

Recruiting

1,000 enrolled

Gastrointestinal

Barrett Esophagus

NCT03961945 2026-01-26

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Phase NA Recruiting

1,550 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Gastroesophageal Reflux

Clinical Trials

Obeticholic Acid for Prevention in Barrett's Esophagus

SLURP

DS-MCE-BE

Impact of RFA on Esophageal Distensibility and Mucosal Impedance

Clinical Utility of WATS3D: A 5-Year Prospective Study

DETECT-ME

Endeavor-1

MAGEC

ESD

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma